The 4 analysts offering 12-month price forecasts for Amphastar Pharmaceuticals Inc have a median target of 37.00, with a high estimate of 40.00 and a low estimate of 35.00. The median estimate represents a +22.60% increase from the last price of 30.18.
The current consensus among 6 polled investment analysts is to Hold stock in Amphastar Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.40
Reporting Date Mar 13
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.